| Sphingosine-1-phosphate reduces CD4+ T-cell activation in type 1 diabetes through regulation of hypoxia-inducible factor short isoform I.1 and CD69. Srinivasan S., Bolick D.T., Lukashev D., Lappas C., Sitkovsky M., Lynch K.R., Hedrick C.C.
Diabetes 57:484-493(2008) · Mapped (3) |
| Eosinophils from lineage-ablated Delta dblGATA bone marrow progenitors: the dblGATA enhancer in the promoter of GATA-1 is not essential for differentiation ex vivo. Dyer K.D., Czapiga M., Foster B., Foster P.S., Kang E.M., Lappas C.M., Moser J.M., Naumann N., Percopo C.M., Siegel S.J. et al.
J. Immunol. 179:1693-1699(2007) · Mapped (10) |
| Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation. Lappas C.M., Day Y.J., Marshall M.A., Engelhard V.H., Linden J.
J. Exp. Med. 203:2639-2648(2006) · Mapped (6) |
| Cutting edge: Critical role for A2A adenosine receptors in the T cell-mediated regulation of colitis. Naganuma M., Wiznerowicz E.B., Lappas C.M., Linden J., Worthington M.T., Ernst P.B.
J. Immunol. 177:2765-2769(2006) · Mapped (3) |
| A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells. Lappas C.M., Rieger J.M., Linden J.
J. Immunol. 174:1073-1080(2005) · Mapped (3) |
| Activation of A2A adenosine receptors inhibits expression of alpha 4/beta 1 integrin (very late antigen-4) on stimulated human neutrophils. Sullivan G.W., Lee D.D., Ross W.G., DiVietro J.A., Lappas C.M., Lawrence M.B., Linden J.
J. Leukoc. Biol. 75:127-134(2004) · Mapped (20) |
| Genome sequence of the plant pathogen and biotechnology agent Agrobacterium tumefaciens C58. Goodner B., Hinkle G., Gattung S., Miller N., Blanchard M., Qurollo B., Goldman B.S., Cao Y., Askenazi M., Halling C. et al.
Science 294:2323-2328(2001) · UniProtKB (5,344) |
in Literature Citations
